Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Receivables - Net of $20 million in fiscal Q3 2026 (quarter ended Aug 31, 2026).

Analysis

Nurix Therapeutics (NRIX) Receivables - Net (2021 - 2026) Analysis & Trends

At the end of FY2021 (ended Nov 30, 2021), Nurix Therapeutics reported Receivables - Net of $6 million.

  • The fiscal Q3 2026 figure is the lowest quarterly Receivables - Net since fiscal Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Nurix Therapeutics 1.73 Bn -891.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 20.00 Mn
May 31, 2025 19.00 Mn
Aug 31, 2023 2.00 Mn
Feb 28, 2022 6.00 Mn
Nov 30, 2021 6.00 Mn
May 31, 2021 2.54 Mn
API Access

Nurix Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=NRIX&period=max&api_key=YOUR_API_KEY